Elevance Health, Inc.
ELVNYSEHealthcareHealthcare Plans
As of Oct 22, 2026 close
- Market cap
- $97.03B
- P/E (TTM)
- 19.55
- Forward P/E
- 21.41
- Dividend yield
- 1.54%
- 52-week range
- $274.84$440.67
- Volume (live)
- -
- Avg. volume (3M)
- 1.27M
Elevance Health (ELV) Stock Price & Financial Analysis
Elevance Health Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $431.20 - $449.95 |
|---|---|
| 52-Week High | $440.67 |
| 52-Week Low | $274.84 |
| Open | $432.56 |
| Volume (last close) | 1.43M |
| Average Volume (3M) | 1.27M |
| Revenue (TTM) | 200.49B |
|---|---|
| Net Income (TTM) | 4.96B |
| Free Cash Flow (TTM) | 6.29B |
| EPS (TTM) | $22.46 |
| Profit Margin | 2.48% |
| Operating Margin | 3.01% |
| Return on Equity (ROE) | 11.02% |
| Debt to Equity | 0.69 |
| Annual Dividend | $6.87 |
|---|---|
| Dividend Yield | 1.54% |
| Payout Ratio | 30.59% |
| Next Dividend Ex-Date | Dec 4, 2026 |
| Market Cap | 97.03B |
|---|---|
| Shares Outstanding | 217.90M |
| P/E Ratio (TTM) | 19.55 |
| Forward P/E | 21.41 |
| Price to Sales (P/S) | 0.48 |
| Price to Book (P/B) | 2.16 |
| EV/EBITDA | 13.75 |
| 50-Day MA | $405.41 |
|---|---|
| 200-Day MA | $370.05 |
| 1-Year Change | +28.59% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Elevance Health at a Glance
As of the Oct 22, 2026 close, Elevance Health (ELV) has a market capitalization of $97.03B. The stock trades at 19.6× trailing earnings, 21.4× forward earnings and 0.5× sales. Over the trailing twelve months it earned $4.96B on revenue of $200.49B (a 2.5% profit margin) and generated $6.29B of free cash flow. Revenue grew 5.6% year over year.
As of its latest reported balance sheet, it holds $10.23B in cash and securities against $31.04B of debt, a net debt position of $20.81B.
Elevance Health pays a quarterly dividend totaling $6.87 per share a year, a 1.54% yield at the Oct 22, 2026 close, with a 31% payout ratio and 14 consecutive years of dividend increases.
The share price is up 28.6% over the past year. At $445.28 (the Oct 22, 2026 close) it sits near the top of its 52-week range of $274.84 to $440.67, above its 200-day moving average of $370.05.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $464.86, 4.4% above the Oct 22, 2026 close.
Frequently Asked Questions About Elevance Health
What is the current stock price for ELV?
As of the Oct 22, 2026 close, ELV stock trades at $445.28. The 52-week range is $274.84–$440.67, with a day range of $431.20–$449.95.
What is the P/E ratio for ELV?
As of the Oct 22, 2026 close, Elevance Health's trailing twelve-month (TTM) P/E ratio is 19.6, meaning investors pay $19.6 for every $1 of annual earnings. The forward P/E is 21.4, reflecting analyst expectations for future earnings. Elevance Health operates in the Healthcare sector.
Does ELV pay dividends?
Yes, Elevance Health pays a 1.54% annual dividend yield as of the Oct 22, 2026 close ($6.87 per share a year). The trailing twelve-month payout ratio is 30.6%. The next ex-dividend date is December 4, 2026.
What do analysts recommend for ELV?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for ELV is Buy. The average 12-month price target is $464.86, a 4.4% upside from the Oct 22, 2026 close of $445.28.
What is the market cap of ELV?
As of the Oct 22, 2026 close, Elevance Health's market capitalization is $97.03B, classifying it as a large-cap company. Elevance Health operates in the Healthcare sector within the Healthcare Plans industry.